|
| 1 | FOR GROUP B-2 (INJECTIONS) |
| 2 | A.C.T.H. 60 I.U. (Inj. Corticotrophin (ACTH) 60IU in 5 ml multidose Vial |
| 3 | Abciximab 2 mg / ml (5 ml) |
| 4 | Adenosine 6 mg / 2 ml |
| 5 | Amino Acid Solution IV 100 ml |
| 6 | Amino Acids (10% v/v) with electrolytes 500 ml |
| 7 | Amino Acids: Nutritive Infusion combination of 8 essential (10.585gm.) & 10 non-essential (10.432 gm.) amino-acids 10% 100 ml |
| 8 | Amino Acids: Nutritive Infusion combination of 8 essential (10.585gm.) & 10 non-essential (10.432 gm.) amino-acids 10% 500 ml |
| 9 | Amrinone 100 mg in dry powder form with 20 ml solvent |
| 10 | Aprotinin 5,00,000 IU / 50 ml in 50 ml |
| 11 | Aq. Ext. of Fresh Human Placenta 0.1 gm containing more than 0.8% Nitrogen w/v per ml, 2 ml |
| 12 | Aqueous micronised Progesterone 100 mg |
| 13 | Aqueous micronised Progesterone 50 mg |
| 14 | Artesunate 120 mg (Dried Powder) |
| 15 | Artesunate 60 mg (Dried Powder) |
| 16 | Basiliximab 20 mg |
| 17 | Beta Interferon 250 mcg / ml in powder form |
| 18 | Caffeine Citrate20 mg / ml, 1 ml |
| 19 | Caffeine Citrate20 mg / ml, 2 ml |
| 20 | Caffeine Citrate 20 mg/ ml3 ml |
| 21 | Calcitriol 1mcg / ml, 1 ml. |
| 22 | Cangrelor 50 mg |
| 23 | Carbetocin 100 mcg / ml, 1 ml |
| 24 | Carboprost 125 mcg / 0.5 ml. |
| 25 | Carboprost 250 mcg / ml, 1 ml. |
| 26 | Chlorpromazine 25 mg |
| 27 | Cross Linked Hyaluronic Acid/ Sodium Hyaluronate90 mg / 3ml PFS |
| 28 | Dalteparin Sodium 5000 IU / ml, 2mlPFS |
| 29 | Dalteparin Sodium 7500 IU / ml, 3 ml PFS |
| 30 | Darbepoietin (r-DNA Origin) 25 mcg |
| 31 | Darbepoietin (r-DNA Origin) 40 mcg |
| 32 | Depot MedroxyProgestron Acetate (DMPA) 150 mg IM |
| 33 | Desferrioxamine (500 mg) |
| 34 | Dexamethasone intra-vitreal Implant (0.7 mg) |
| 35 | Dextronomer Hyaluronic Acid(Dextronomer 50 mg + Stabilized Sodium Hyaluronate 15 mg) 1 ml |
| 36 | Dextrose 25% I.V. 100 ml |
| 37 | Dextrose 50% I.V. 25 ml |
| 38 | Diazepam 10 mg |
| 39 | Diclofenac Sodium 25 mg / ml IM (3 ml) |
| 40 | Dicyclomine HCL 20 mg |
| 41 | Digoxin 0.5 mg / 2 ml. |
| 42 | Docaravimab and Miromavimab 1500 IU 2.5 ml (Cocktail of two monoclonal anti body) |
| 43 | Drotaverine 80 mg /2 ml |
| 44 | E- Aminocaprionic acid 50 mg / ml |
| 45 | Eachml contains : Diperoxochloric acid concentrate0.29 mg in 7.5 ml pack with Sodium chloride solution 0.9% w/v 22.5 ml, 30ml |
| 46 | Each 1 ml contains 215.2 mg of Porcine brain derived peptide preparation (Cerebrolysin concentrate) in Aqeous solution, 10 ml |
| 47 | Each ml 1% Sodium Hyaluronate solution contains: Sodium Hyaluronate BP 8 mg, Sodium Chloride IP 8.5 mg, Di-sodium Hydrogen Phosphate Di-hydrate USP 0.16 mg,Monosodium phosphate monohydrate IP 0.04 mg &Water for Injection IP q.s. in 2 ml PFS |
| 48 | Edaravone 30 mg / 20 ml |
| 49 | Enalpril 1.25 mg / ml.(1 ml) |
| 50 | Enoxaparin (LMW Heparin) 0.2 ml / 20 mg PFS |
| 51 | Enoxaparin (LMW Heparin) 0.4 ml / 40 mg PFS |
| 52 | Enoxaparin (LMW Heparin) 0.6 ml / 60 mg PFS |
| 53 | Epsilon Amino caprioic acid 250 mg / ml, 20 ml multi dose Vial |
| 54 | Eptifibitide Bolus 2 mg. / 10 ml |
| 55 | Eptifibitide Infusion 75 mg. / 100 ml |
| 56 | Erythropoietin 10,000 I.U. PFS |
| 57 | Erythropoietin 20,000 I.U. |
| 58 | Erythropoietin 20,000 IU Multidose disposable pen |
| 59 | Erythropoietin 4,000 I.U. PFS |
| 60 | Esmolol HCL 100 mg / 10 ml |
| 61 | Etanercept (25 mg) / 1 ml PFS |
| 62 | Etanercept (50 mg) / 1 ml PFS |
| 63 | Ethamsylate 250 mg / 2 ml |
| 64 | Etophylline 169.4 mg + Theophylline 50.6 mg per 2 ml. |
| 65 | Evolocumab solution for Injection 140 mg / ml |
| 66 | Ferric Carboxymaltose 50 mg / ml (10 ml) |
| 67 | Ferric carboxymaltose equivalent to elemntal iron 50 mg/ ml (2 ml) |
| 68 | Flumazenil (0.1 mg / ml) in 5 ml |
| 69 | Flupenthixol depot 20 mg / ml, 1 ml |
| 70 | Fluphenazine decanoate 25 mg / ml (5 ml) |
| 71 | Folinic Acid 50 mg / 5 ml |
| 72 | Follitrophin 150 IU |
| 73 | Glatiramer Acetate 40 mg/ 1 ml |
| 74 | Glutathione 1200 mg /Vial Lyophilized |
| 75 | Glutathione 2000 mg /Vial Lyophilized |
| 76 | Glutathione 600 mg/Vial Lyophilized |
| 77 | Glycine Irrigation 1.5% 3,000 ml |
| 78 | GnRH Analog Triptoreline 0.1 mg Vial (Powder Form) |
| 79 | GnRH Analog Triptoreline 3.75 mg Vial (Powder Form) |
| 80 | Golimumab (50 mg / 0.5 ml PFS) |
| 81 | Granisetron 1 mg / 1 ml in powder form |
| 82 | Granisetron 4 mg / 4 ml in powder form |
| 83 | Haloperidol 5 mg / ml 1 ml. |
| 84 | Heloperidol 5 mg / ml (10 ml multidose Vial) |
| 85 | Heparin 10 IU per ml |
| 86 | Human Chorionic Gonadotrophin 5,000 I.U/ 1 ml in 1 ml |
| 87 | Human Chorionic Gonadotrophin 10,000 I.U / 1 ml in 1 ml |
| 88 | Human Fibrinogen EP 1 Gm |
| 89 | Human growth harmone somatropin r-DNA origin 10 mg/ 1.5 ml |
| 90 | Human growth harmone somatropin r-DNA origin 15 mg/ 1.5 ml |
| 91 | Human Growth Hormone Somatropin 4 IU Vial in dry powder form |
| 92 | Human Insulin Analoge (Biosynthetic r-DNA Origin) Soluble Insulin aspart 100 IU/ ml in 10 ml |
| 93 | Human Insulin Analoge (Biosynthetic r-DNA Origin) Soluble Insulin aspart 100 IU/ ml in 3 ml cartridges |
| 94 | Human Insulin Analoge (Biosynthetic r-DNA Origin) soluble Insulin aspart 100 IU/ ml in 3 ml prefilled precision delivery device |
| 95 | Hyaluronate solution(Each ml contain Sodium Hyaluronate BP10 mg, Sodium chloride IP 8.5 mg, di-sodium hydrogen phosphate dihydrate USP 0.16 mg, Monosodium phosphate monohydrate IP 0.04 mg & water for injection IP qs) in 6 ml PFS |
| 96 | Hyaluronidase 1,500 I.U. (1 ml.) |
| 97 | Hydralizine Hcl 20 mg I.V. in 1 ml |
| 98 | Hydrocortisone 500 mg + Ascorbic Acid 1.5 gm + Thiamine 200 mg |
| 99 | Hydroxocobalamin 1000 mg |
| 100 | Hydroxy Propyl Methyl Cellouse 2% in 2 ml PFS |
| 101 | Hydroxyprogesterone Caproate 500 mg /2 ml |
| 102 | Hydroxyzine Hcl 25 mg / ml 2 ml. |
| 103 | Hyoscine Butyl Bromide 20 mg / ml, 1 ml. |
| 104 | Hypertonic Saline 3% |
| 105 | Ibandronate 6 mg / 6 ml |
| 106 | Ibutilide famurate 1 mg /10 ml |
| 107 | Infliximab powder 100 mg |
| 108 | Insulin Dagludec/ Insulin aspart (r-DNA origin) solution for subcutaneous 1 ml solution contain 100 IU insulin Dagludec and insulin aspart (70% soluble insulin dagludec and 30% soluble insulin aspart) equivalent to 2.56 mg salt free anhydrous insulin dagludec and 1.05 mg salt free anhydrous insulin apart in 3 ml prefilled pen |
| 109 | Insulin Degludec (r-DNA Origin) Solution for subcutaneous injection, 1 ml solution contains 100 unit of insulin Degludec (equivalant to 3.66 mg) 3 ml prefilled pen |
| 110 | Insulin- glargine (100 iu / ml) 3 ml |
| 111 | Insulin- glargine (100 iu / ml) 5 ml |
| 112 | Insulin- glargine (300 iu / ml) 1.5 ml |
| 113 | Insulin lispro Protamine suspension 75 % + Insulin Lispro 25 %3 ml Cartridge |
| 114 | Insulin-Glulisine 100IU/ml solution for 3ml |
| 115 | Insulin-Mixture of 25%, Neutral insulin+ 75% Isophane Human insulin 100 IU/ ml, 3 ml cartridge |
| 116 | Insulin-mono-component (Biphasic Human) 40 IU per ml, 10 ml (30:70) |
| 117 | Insulin-NPH 40 I.U./ ml (10 ml) |
| 118 | Insulin-Plain 40 I.U./ ml (10 ml) |
| 119 | Iron (III) isomeltoside 1000 equivalant to elemental iron 100 mg/ ml |
| 120 | Iron Sucrose (equivalent to 50 mg of elemental iron / 2.5 ml) I.M./I.V. 5 ml. |
| 121 | Isotonic Balanced Crystalloid Soloution (Fully Plasma adapted) 500 ml bottle |
| 122 | Isotonic balanced Crystalloid Solution with calcium 500 ml(Fully plasma Adapted) |
| 123 | Isoxsuprine HCL 5 mg / ml (2 ml.) |
| 124 | L-Alanyl-L-Glutamine 20%50 ml IV |
| 125 | Levetiracetam 500 mg / 5 ml |
| 126 | Levonorgestral 52 mg ( Hormone ) intrauterine delivery system releasing 20 mcg / day |
| 127 | Levosimendan 12.5 mg Lypholised Vial with diluent |
| 128 | Lorazepam 2 mg / ml in 1ml |
| 129 | Medroxy Progesterone 150 mg / ml 1 ml |
| 130 | Mehthylene Blue 1% (10 mg / ml) Single doseVial |
| 131 | Menotrophin 150 I.U. in freeze dried powder form with diluent |
| 132 | Menotrophin 75 I.U. in freeze dried powder form with diluent |
| 133 | Mepolizumab 100 mg Vial in powder form |
| 134 | Metheylergometerine 0.2 mg / ml (1 ml.) |
| 135 | Methocarbamol 100 mg / 10 ml |
| 136 | Methyl Prednisolone 1 Gm (powder form) |
| 137 | Methyl prednisolone 40 mg / ml |
| 138 | Methyl Prednisolone 500 mg (powder form) |
| 139 | Milrinone 10 mg / 10 ml |
| 140 | Multi Vitamin IV 10 ml |
| 141 | N-Acetyl Cystine 200 mg / ml 30 ml |
| 142 | Nandrolone Phenyl Propionate 25 mg / ml (1 ml.) |
| 143 | NandroloneDoconate 50 mg / ml (1ml.) |
| 144 | Niacinamide 200 mg, Folic acid 15 mg cyanocobalamin 500 mcg IV/IM 10 ml |
| 145 | Nicorandil 2 mg / ml |
| 146 | Nitroglycerine 25 mg / 5 ml. |
| 147 | Normal Saline 0.9% Sodium Chloride For Irrigation 3,000 ml Pack |
| 148 | Normal saline poly bag 0.9 % w/v |
| 149 | Octreotide 100 mcg/ 1 ml |
| 150 | Octreotide 50 mcg / 1 ml |
| 151 | Olanzapine 10 mg Vial Lyophilized |
| 152 | Olanzapine Long Acting 210 mg |
| 153 | Olanzapine Pamoate LA 300 mg / Vial powder for suspension |
| 154 | Omeprazole40 mg / 10 mlVial lypholised |
| 155 | Onabotulinum toxin type-A 200 I.U. |
| 156 | Onabotulinum toxin type-A 50 I.U. |
| 157 | Onabotulinum toxin type-A 100 I.U. |
| 158 | Oxytocin 5 I.U. / ml1 ml. |
| 159 | Palonosetron HCl 0.25 mg / 5 ml |
| 160 | Pamidronate 60 mg / 10 ml |
| 161 | Pamidronate 90 mg / 10 ml |
| 162 | Pancuronium 4 mg / 2 ml |
| 163 | Papaverine 30 mg / ml 2 ml |
| 164 | Papaverine 30 mg / ml10 ml |
| 165 | Paracetamol 150 mg / ml, 2 ml - IM |
| 166 | Peg Intaferon Alpha 2b 100 mcg / 0.5 mldry powder form |
| 167 | Peg Intaferon Alpha 2b 80 mcg / 0.5 ml dry powder form |
| 168 | Peglyated Interferon Beta -1a,125 mcg / 0.5 ml PFS |
| 169 | Pegylated recombinant Human Erythropoientin 100 mcg/0.3 ml |
| 170 | Pegylated recombinant Human Erythropoientin 50 mcg/0.3 ml |
| 171 | Pegylated recombinant Human Erythropoientin 75 mcg/0.3 ml |
| 172 | Pheniramine Maleate 22.75 mg / ml 2 ml |
| 173 | Phenobarbitone 200 mg / ml 1 ml |
| 174 | Phenoxybenzamine 50 mg / ml (1 ml) |
| 175 | Phenytoin sodium 50 mg / ml (2 ml.) |
| 176 | Pilocarpine 0.5% w/v for intracameral use |
| 177 | Polidocanol 60 mg/ 2 ml |
| 178 | Polymer from degraded gelatine 3.5 gm. (Equivalent to Nitrogen content of 0.63gm) Electrolytes Na+ 145.0, K+ 5.1 Ca+ 12.5 Meq/liter (6.25 m mol/liter) & CI-145.0 all expressed in Meq/liter, sterile distilled water (Pyrogen free) to 100 ml made Isotonic with polypeptides 500 ml Bottle |
| 179 | Porcine natural source Lung Surfactant (concentration of 80 mg / ml) 3 ml |
| 180 | Porcine natural source Lung Surfactant (concentration of 80 mg / ml) 1.5 ml |
| 181 | Porcine natural source sterile suspension (phospholipid concentration 80 mg / ml)for suitable storage in 2 to 8 degree celcius 3 ml |
| 182 | Porcine natural source sterile suspension (phospholipid concentration 80 mg / ml) for suitable storage in 2 to 8 degree celcius 1.5 ml |
| 183 | Potassium Phosphate 15ml |
| 184 | Premixed Human Insulin Analoge (Biosynthetic r-DNA Origin) mixture of soluble Insulin aspart and Protamine crystallized insulin aspart 100 IU/ ml in 3 ml precision delivery device prefilled |
| 185 | Procainamide 100 mg / ml, 10 ml |
| 186 | Prochlorperazine Maleate 12.5 mg / ml, 1 ml. |
| 187 | Prostaglandin 15 methyl F2 Alpha tromethamine 250 ug / ml |
| 188 | Prostaglandin E1/Alprostadil 500 mcg / 1 ml, 5 ml. |
| 189 | Pulmonary Surfactant containing Bovine Lung extract Beractant4 ml – 25 mg / ml |
| 190 | Pulmonary Surfactant containing Bovine Lung extract Beractant8 ml – 25 mg / ml |
| 191 | Ranibizumab Intra Vitreal 10 mg / ml |
| 192 | Ranibizumab Intra Vitreal 6 mg / ml |
| 193 | Ranitidine 50 mg / 2 ml |
| 194 | Rapid acting Insulin Analouge 100 IU/ml 3 ml cartridges |
| 195 | Rasburicase 3 mg /Vial with diluent in dry powder form |
| 196 | Recombinant Human Tissue Type Plasminogen Activator Alteplase 20 mg - 1 Vial of powder containing 20 mg Alteplase with 1 Vial of 20 ml Solvent |
| 197 | Recombinant Human Tissue Type Plasminogen Activator Alteplase 50 mg - 1 Vial of powder containing 50 mg Alteplase with 1 Vial of 50 ml Solvent |
| 198 | Recombinant Tissue Plasmagen Actiator Reteplase 18 mg / Vial in powder form |
| 199 | Recombinant Tissue Plasminogen Activator Tenecteplase 30 mg in Lypholised Powder form |
| 200 | Recombinant Tissue Plasminogen Activator Tenecteplase 40 mg in Lypholised Powder form |
| 201 | Recombinent Tissue Plasmogen Activator Tenecteplase 20 mg in Lypholised Powder form |
| 202 | Risperidone25 mg / 2 ml |
| 203 | Risperidone 37.5 mg / 2 ml |
| 204 | Ritodrine HCL l0 mg / ml 5 ml |
| 205 | Sildenafil 10 mg per 12.5 ml (0.8 mg / ml) |
| 206 | SMOF (soybean oil, MCT oil, olive oil, and fish oil) 20% Lipid Emulsion 100 ml |
| 207 | Sodium ferric gluconate complex 125 mg / 10 ml |
| 208 | Sodium Hyaluronate 10 mg / ml2 ml |
| 209 | Sodium Hyaluronate 18 mg / ml opth. Sol. 1 ml PFS |
| 210 | Sodium Pentosan Polysulfate Instil 30ml |
| 211 | Sodium tetra decylsulphate 2% (30 mg / ml)2 ml |
| 212 | Sodium Valporate 100 mg / ml 5 ml. |
| 213 | Somatostatin 4 IU |
| 214 | St. Thomas Hospital Cardioplegia Solution(NaCl 110.0mM, NaHCO310.0mM,KCL16.0mM, MgCl 2 12.16OmM, CaCl 2.2mM,Ph7.8)- 20 ml |
| 215 | Streptokinase 15 Lac unit / Vial Lypholised |
| 216 | Succinyl Choline Chloride 100 mg / 2 ml. |
| 217 | Terbutaline Sulphate 0.5 mg / ml (1 ml.) |
| 218 | Teriparatide 750 mcg / 3 ml in 3 ml PFS |
| 219 | Terlipressin 1 mg / 10 ml in 10 ml. |
| 220 | Tetracosactide acetate 250 mcg1 ml. |
| 221 | Thiamine 100 mg |
| 222 | Tirofiban HCL 5 mg / 100 ml in 100 ml |
| 223 | Toclizumab 200 mg /10 ml of concentrate for solution |
| 224 | Toclizumab 400 mg /10 ml of concentrate for solution |
| 225 | Torsemide 10 mg / ml, (2 ml) |
| 226 | TPN 3 in 1 for ready to use bag for use in preterm neonates with glucose, amino acid & lipids (lipid 20%) (A.A. 10%) 100 ml Pack |
| 227 | Trace Elements (Zinc Cl 6.5 mg+ Copper Chloride 1.3 mg + manganese Chloride 0.27 mg + Chromic Chloride 5 mcg + Ferric Chloride 0.55 mg + Sodium Molybidate 19 mcg + Pot. Iodide 0.13 mg + Sod. Fluoride 0.95 mg) 10 ml |
| 228 | Trenaxamic Acid 500 mg (5 ml) |
| 229 | Triamcinolone Acetate 10 mg / ml (5 ml) |
| 230 | Triamcinolone Acetate 40 mg / ml (5 ml) |
| 231 | Triamcinolone Acetonide 10 mg / ml (5 ml) |
| 232 | Triamcinolone Acetonide 40 mg / ml (5 ml) |
| 233 | Trypan Blue Dye (0.06%) |
| 234 | Ulinastatin 1,00,000 IU in 5 ml. |
| 235 | Urofollitropin 75 I.U. ( Pure FSH ) Dry powder form |
| 236 | Urokinase 5,00,000 I.U. Lypholised Vial |
| 237 | Valethamate Bromide 8 mg / ml (1 ml.) |
| 238 | Verpamil HCL 5 mg / 2 ml |
| 239 | Vit. A 1 Lac Unit (2 ml.) |
| 240 | Vit. B-1(100 mg) +B-6 (100 mg) +B-12 (1000 mcg) 3ml. |
| 241 | Vit. C 500 mg / 5 ml. |
| 242 | Vit. D 3 Lac Unit / Amp. of 1 ml |
| 243 | Vit. D 6 Lac Unit / Amp. of 1 ml |
| 244 | Water for Injection (5 ml) Amp. |